NCT00695019 - Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C | Biotech Hunter

Enrollment

169

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

February 29, 2012

Conditions

Hepatitis C, Chronic

Interventions

DRUG

interferon-alpha lozenges

500 IU lozenges of natural human interferon-alpha for oral dissolution given once or three times per day for 24 weeks

DRUG

placebo lozenges

200 mg matching placebo lozenges

Trial Locations (9)

Chang Gung Memorial Hospital, Taipei

Dalin Buddhist Tzu Chi General Hospital, Dalin

Kaohsiung Chang Gung Memorial Hospital, Niaosong

Show-Chwan Memorial Hospital, Changhua

Chiayi Chang Gung Memorial Hospital, Chiayi City

Chiayi Christian Hospital, Chiayi City

Keelung Chang Gung Memorial Hospital, Keelung

China Medical University Hospital, Taichung

Taipei Veterans General Hospital, Taipei